Analyst Reco. Edwards Lifesciences Corporation Borsa Italiana

Equities

4EW

US28176E1082

Real-time Estimate Tradegate Other stock markets 01:30:00 10/05/2024 am IST			5-day change	1st Jan Change
81.08 ^EUR	+1.77%		-0.14%	+14.50%

01:21am	Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	CI
07/05	Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100	07/05	MT
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	02/05	MT
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	01/05	MT
Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72	29/04	MT
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92	26/04	MT
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83	26/04	MT
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $99 From $94	26/04	MT
UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating	26/04	MT
Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85	26/04	MT
Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86	26/04	MT
Baird Adjusts Edwards Lifesciences Price Target to $102 From $100	17/04	MT
Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating	17/04	MT
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	16/04
Zacks Investment Research Adjusts Price Target on Edwards Lifesciences to $95 From $97	15/04	MT
Truist Securities Adjusts Edwards Lifesciences Price Target to $105 From $97, Buy Rating Kept	15/04	MT
RBC Raises Price Target on Edwards Lifesciences to $101 From $95, Keeps Outperform Rating	15/04	MT
Mizuho Securities Adjusts Price Target on Edwards Lifesciences to $105 From $95, Maintains Buy Rating	11/04	MT
Edwards Lifesciences Insider Sold Shares Worth $1,154,142, According to a Recent SEC Filing	09/04	MT
Edwards Lifesciences Insider Sold Shares Worth $1,329,472, According to a Recent SEC Filing	09/04	MT
Edwards Lifesciences Insider Sold Shares Worth $2,712,418, According to a Recent SEC Filing	05/04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 08:55 pm IST